Rolls Royce’s $400,000 SUV helps luxury carmaker set new sales record for 2019

The Rolls-Royce Cullinan at the Geneva International Motor Show 2019.

Martyn Lucy | Getty Images

Rolls-Royce had its best year ever in 2019, driven in large part by its three-ton SUV that sells for over $400,000.

The company, a division of BMW, said it sold 5,152 cars last year, the most in its history. That marked a 25% increase over the 4,107 vehicles it sold in 2018.

The main drive was the new Rolls-Royce Cullinan, a hulking giant of an SUV that starts at $330,000 but typically retails for over $400,000 with the usual add-ons and customizations.

Rolls-Royce — like many high-end car brands branching into SUVs – walks a delicate line between growing sales and keeping its brand special. The company said that it expects sales to “stabilize” next year.

“While we celebrate these remarkable results, we are conscious of our key promise to our customers, to keep our brand rare and exclusive,” said Rolls-Royce’s CEO, Torsten Muller-Otvos.

The biggest challenge for Rolls-Royce is keeping up with demand. The company said it is making “significant” investments in its Goodwood plant in England, hiring workers and recruiting a record number of people for its apprenticeship program.

The company reported strong growth worldwide, with North America still its largest market, at about a third of its sales, followed by China and Europe. Russia, Singapore, Australia and Japan all reported record sales.

Since 2019 was the first full year of delivery for the Cullinan, the SUV drove the bulk of the sales growth, though the company doesn’t break out exact model figures. While many critics and auto experts dismissed the Cullinan as too big, too expensive or too mass-market, it became the fastest-selling new model in Rolls-Royce’s history.

Products You May Like

Articles You May Like

Dividend stocks look attractive with a volatile year that nets measly returns expected ahead
Bills in several states aim to help those in the gig economy. Some are worried they’ll lose work instead
Why 2020 could be a big year for international stocks over US equities
Health-care companies use technology and data to boost primary care services

Leave a Reply

Your email address will not be published. Required fields are marked *